Literature DB >> 21774992

Weight gain in relation to major depression and antidepressant medication use.

Scott B Patten1, Jeanne V A Williams, Dina H Lavorato, Salma Khaled, Andrew G M Bulloch.   

Abstract

BACKGROUND: Previous studies have linked major depressive episodes (MDEs) to obesity. The association may be partially mediated by antidepressant medication use. In the current study we examine changes in weight and BMI in relation to MDE and antidepressant use in a general population cohort.
METHODS: Data from a Canadian longitudinal study, the National Population Health Survey (NPHS) were used. The NPHS has collected data from a community cohort since 1994 using interviews spaced two years apart. The NPHS includes the Composite International Diagnostic Interview Short Form for Major Depression (CIDI-SFMD). Self-reported height and weight are also recorded. Linear regression was used to describe associations between weight, BMI and MDE.
RESULTS: The pattern of weight change varied by age. Respondents under the age of 65 tended to gain weight over time, whereas those over the age of 65 tended to lose weight. Respondents in the younger category gained more weight if they had MDE or took antidepressant medications. However, the extent of weight gain was modest, those with MDE and those taking an antidepressant gaining an average of approximately 1 kg over 12 years of follow-up. LIMITATIONS: The study used self-reported weight, which may be inaccurate. Measurements were made two years apart. The measure of MDE was an abbreviated diagnostic interview.
CONCLUSIONS: Both MDE and antidepressant medication use are associated with a modest increase in weight in people under 65. These results may be useful for physicians and other health professionals in planning dietary and weight-management regimens for depressed patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774992     DOI: 10.1016/j.jad.2011.06.027

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  14 in total

1.  Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.

Authors:  Li-Tzy Wu; Udi E Ghitza; Bryan C Batch; Michael J Pencina; Leoncio Flavio Rojas; Benjamin A Goldstein; Tony Schibler; Ashley A Dunham; Shelley Rusincovitch; Kathleen T Brady
Journal:  Drug Alcohol Depend       Date:  2015-09-12       Impact factor: 4.492

2.  Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant medication users and non-users: a randomized controlled trial.

Authors:  Ikuyo Imayama; Catherine M Alfano; Caitlin Mason; Chiachi Wang; Catherine Duggan; Kristin L Campbell; Angela Kong; Karen E Foster-Schubert; George L Blackburn; Ching-Yun Wang; Anne McTiernan
Journal:  Prev Med       Date:  2013-07-13       Impact factor: 4.018

Review 3.  [Nutrition and dietary supplements in psychiatric diseases].

Authors:  H Himmerich; F Erbguth
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

4.  Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.

Authors:  Jess G Fiedorowicz; Lisa Brown; James Li; Sagar V Parikh; Boadie W Dunlop; Brent P Forester; Richard C Shelton; Michael E Thase; Matthew Macaluso; Kunbo Yu; John F Greden
Journal:  Psychopharmacol Bull       Date:  2021-11-03

5.  Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research.

Authors:  Sebastien Haneuse
Journal:  Med Care       Date:  2016-04       Impact factor: 2.983

6.  Medical students' attitudes towards overweight and obesity.

Authors:  Birte Pantenburg; Claudia Sikorski; Melanie Luppa; Georg Schomerus; Hans-Helmut König; Perla Werner; Steffi G Riedel-Heller
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

Review 7.  Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.

Authors:  Eliane A Lucassen; Kristina I Rother; Giovanni Cizza
Journal:  Ann N Y Acad Sci       Date:  2012-07-24       Impact factor: 5.691

8.  Metabolic Disturbances in Rat Sublines with Constitutionally Altered Serotonin Homeostasis.

Authors:  Maja Kesić; Petra Baković; Ranko Stojković; Jasminka Štefulj; Lipa Čičin-Šain
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  Influence of body mass index on the choice of therapy for depression and follow-up care.

Authors:  Denise M Boudreau; David Arterburn; Andy Bogart; Sebastien Haneuse; Mary Kay Theis; Emily Westbrook; Greg Simon
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

10.  Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population.

Authors:  Z Samaan; S Garasia; H C Gerstein; J C Engert; V Mohan; R Diaz; S S Anand; D Meyre
Journal:  Transl Psychiatry       Date:  2015-08-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.